Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

V.FRXI , C.AIML , V.NEXE , C.CGII , C.TUGA , C.HYTN , C.TELI
Sort by: Date|Relevance

From now on, dynaCERT instead of Bitcoin or NVIDIA?

While Bitcoin and NVIDIA dominate the headlines and investors hope for the next rally, a promising opportunity is emerging with dynaCERT Inc. (ISIN: CA26780A1084 | Ticker-TSX: DYA) for those seeking a true growth story. Read on to learn why this Canadian company may now b...

The company revolutionizing access to care and natural remedies

The Market Online recently spoke with Liz Viccars, CEO of AJA Health and Wellness Inc. (TSXV:AJA) a company transforming healthcare with its total health access service offering telemedicine, diagnostics and specialized care via proprietary tech. Additionally, AJA Heal...

Visionstate set to leverage success in the U.S. market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Visionstate Corp (TSXV:VIS) , a company whose vision is to be the leading global provider of IoT solutions for facility management. Their flagship software WANDA i...

Debt-free cannabis company set for next stage of growth

The following is a transcription of the above video, and The Market Online has edited it for clarity . Nextleaf Solutions (CSE:OILS) , is a debt-free cannabis processor known for its multi patented, scalable extraction technology. The company offers a diverse portfo...

Buzz on the Bullboards: TSX stocks to watch after Trump’s win

The past week the TSX and Wall Street saw a significant surge following Donald Trump’s return to the presidency. This political shift is expected to have profound implications for various sectors, particularly the financial and energy industries. Inv...

Leading Edge Materials: Positioning for the EU’s critical minerals push

By David Yeoman, Crux Investor Leading Edge Materials has a portfolio of critical raw materials projects in the EU, including the Norra Kärr heavy rare earths project in Sweden, the Woxna graphite mine in Sweden, and an exploration program in Romania. ...

Buzz on the Bullboards: Despite energy woes, TSX hits new high

This week, the TSX endured fluctuations but ultimately achieved a new high in intraday trading. The tech sector has been a significant driver of these gains, thanks to a solid performance among top stocks in the sector. One of Canada’s leading te...

Not only balloons: Use-cases and key players in global helium market

Whether you’re seeking exposure to exploration upside or established profitability, the helium market offers compelling candidates for the commodity sleeve of your portfolio. Helium is an essential resource notable for its widespread use-cases and p...

DynaCERT: Is this the hour of hydrogen?

Daimler Truck must reduce forecasts It is a challenging time for transportation companies. By 2030, fleet operators in the EU will have to meet specific requirements to reduce CO2 emissions. The EU has introduced stricter CO2 standards for heavy-duty vehicles, requi...

Revolutionizing immunotherapies with groundbreaking DPX platform

The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...
1 2 3 4 5 6 7 8 9 10 ...